| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Revenue | $1.2B | $1.0B | $0.9B | $0.9B | $0.8B |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| R&D Expense | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — |
| Operating Income | $0.6B | $0.5B | $0.5B | $0.5B | $0.4B |
| Net Income | $0.4B | $0.4B | $0.4B | $0.4B | $0.3B |
| EPS (Basic) | $4.34 | $3.63 | $3.97 | $3.83 | $3.17 |
| EPS (Diluted) | $4.30 | $3.60 | $3.94 | $3.81 | $3.16 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Total Assets | $10.1B | $9.9B | $9.0B | $8.8B | $8.2B |
| Current Assets | $0.3B | $0.3B | $0.3B | $0.3B | $0.4B |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Total Liabilities | $5.2B | $5.2B | $4.7B | $4.7B | $4.1B |
| Current Liabilities | $0.3B | $0.4B | $0.4B | $0.6B | $0.2B |
| Stockholders' Equity | $4.7B | $4.6B | $4.1B | $4.0B | $3.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.9B | $0.8B | $0.8B | $0.7B | $0.6B |
| Investing Cash Flow | $-0.4B | $-1.1B | $-0.4B | $-0.9B | $0.1B |
| Capital Expenditures | $0.4B | $0.3B | $0.8B | $0.3B | $0.1B |
| Financing Cash Flow | $-0.5B | $0.3B | $-0.5B | $0.1B | $-0.6B |